MetabolicDPP-4 inhibitorScheduled campaign
Sitagliptin phosphate
Also known as Januvia
A dipeptidyl peptidase-4 inhibitor for type 2 diabetes. Manufactured under a validated asymmetric synthesis with chiral purity control.
Full specification
Identity, quality, and supply.
- INN
- Sitagliptin phosphate
- CAS number
- 654671-77-9
- Molecular formula
- C16H15F6N5O·H3PO4·H2O
- Molecular weight
- 523.3 g/mol
- Therapeutic area
- Metabolic
- Therapeutic class
- DPP-4 inhibitor
- Supplied as
- API
- Available scale
- Commercial
- Stock status
- Scheduled campaign
- Storage
- As per COA
- Packaging
- HDPE drums, 25 kg net weight
- Brand names
- Januvia
Highlights
What buyers care about.
- Asymmetric synthesis with enantiomeric excess ≥99.9%
- MHRA-inspected site